Japanese drugmaker Takeda Pharmaceutical said on Wednesday it will discontinue its cell therapy research and look for a partner to advance candidates under development.

Danaher Corporation is undervalued, with strong fundamentals, robust free cash flow, and 12.7% upside. Click here to read why DHR stock is a Buy.

Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness surrounding national health security. And it is possible—if done right.

Francer is Lilly’s vice president, head of global regulatory policy and strategy. Cruz is Lilly’s senior vice president, corporate engineering & global health, safety and environmental.

President Donald Trump is planning big tariffs on pharmaceuticals, kitchen counters, bathroom vanities, upholstered furniture and heavy trucks ...

President Trump announced a 100% tariff on pharmaceutical drugs, a 50% tariff on kitchen cabinets and bathroom vanities, a 30% tariff on upholstered furniture and a 25% tariff on heavy trucks.

As manufacturers shore up investments in emerging technologies and domestic production capacity, a strategic EAM approach is mission-critical for compliance.

US President Donald Trump announced 100% tariffs on branded and patented drugs from October 1, 2025, alongside new tariffs on furniture and trucks, with implications for Indian pharma exports ...